-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Compass Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2018 to Q2 2024.
- Compass Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$13.1M, a 15.9% decline year-over-year.
- Compass Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$47.2M, a 10.7% decline year-over-year.
- Compass Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$42.5M, a 8.33% decline from 2022.
- Compass Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$39.2M, a 52.3% increase from 2021.
- Compass Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$82.2M, a 179% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)